Bioprinting in regenerative medicine

In the paper “Three‐Dimensional Bioprinting in Regenerative Medicine: Reality, Hype, and Future,” authors Anthony Atala and Gabor Forgacs explore some necessary topics within 3D printing and bioprinting. The technology has brought forth incredible innovation capable of transforming manufacturing, design mechanisms, and offering never dreamed of self-sustainability that could be even more useful in the future

Read More


Graphene 3D printing

As discoveries around graphene applications abound, many are wondering if it can be scaled to 3D. This could have revolutionary effects, but it begs the question, have scientists been successful in graphene 3D printing? Find out! GRAPHENE 3D PRINTING Is It Possible? So, is it possible to 3D print graphene? The short answers is, not

Read More


Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use

Orgenesis Inc., a developer, manufacturer and service provider of advanced cell therapies, today announced that it has entered into a collaboration agreement with Digilab Inc. to develop a live cell printing process and systems designed to automate the production of three-dimensional live cellular structures and tissues.  Under the Agreement, Orgenesis will have the exclusive rights

Read More


In Situ Bioprinting of Autologous Skin Cells Accelerates Wound Healing of Extensive Excisional Full-Thickness Wounds

01 March 2019 P.M.Fornasari While the advent of 3D printers is commonly thought of as a revolution for manufacturing, it could have huge benefits for medicine as well. To help patch up large wounds that might normally require a skin graft, researchers at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed a new bioprinter

Read More


Procter & Gamble Partners with Aether to Advance AI-Driven 3D Bioprinting

The 3D printing and AI startup Aether has reached a two-year joint agreement with Procter & Gamble to further develop its AI-driven 3D bioprinting system into an “intelligent robotic craftsman”. Procter & Gamble, the multinational consumer goods giant, has agreed to a two-year developmental agreement with the San Francisco-based 3D printing and AI startup Aether.

Read More